financetom
Business
financetom
/
Business
/
Canada's No.1 lender RBC posts rare profit miss, CIBC beats
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canada's No.1 lender RBC posts rare profit miss, CIBC beats
May 29, 2025 4:38 AM

*

RBC second quarter earnings per share C$3.12 vs forecast

C$3.19

*

CIBC second quarter earnings per share C$2.05 vs forecast

C$1.89

*

Both banks set aside more than expected for possible loan

losses

May 29 (Reuters) - Royal Bank of Canada ( RY ) on

Thursday missed analysts' quarterly profit estimates as loan

loss provisions jumped and a slowdown in dealmaking in the

United States hurt its capital markets business.

The miss is RBC's first in two years and contrasts with peer

Canadian Imperial Bank of Commerce ( CM ), which topped

estimates as its earnings from capital markets rose 20%.

Both banks, however, set aside more funds than anticipated

to cover potential loan defaults, as a changing economic outlook

is expected to lead to more caution among borrowers.

RBC, like some of its peers, has made a push into the United

States, seeking growth opportunities away from home, where it

has tightened its grip as the largest lender with the C$13.5

billion acquisition of HSBC Canada last year.

The capital markets unit, RBC's second largest income

generator, saw a 5% fall in net income, hurt by lower fixed

income trading and lower M&A activity in the United States.

At CIBC, that unit saw a 20% jump in earnings, helped by

higher financing and trading revenue.

"CIBC reported a good set of results ... credit continued to

outperform peers with a group-low PCL (provision for credit

losses) ratio on impaired loans this quarter," Scotiabank

analyst Mike Rizvanovic said.

RBC's provision for credit losses jumped 55% to C$1.42

billion in the second quarter, higher than analysts' estimate of

C$1.13 billion, according to LSEG data.

Adjusted profit rose 8% to C$4.53 billion ($3.28 billion).

On a per share basis, RBC earned C$3.12, missing the estimated

C$3.19.

CIBC's provisions rose C$91 million to C$605 million,

compared with an estimated C$601 million. Earnings of C$2.05 per

share surpassed analysts' average estimate of C$1.89.

RBC and CIBC wrap up second quarter earnings for Canada's

six big banks, which saw a marked rise in loan loss reserves as

they prepare for the economic impact of U.S. tariffs and a

global trade war.

($1 = 1.3821 Canadian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dream Finders Homes Insider Sold Shares Worth $568,433, According to a Recent SEC Filing
Dream Finders Homes Insider Sold Shares Worth $568,433, According to a Recent SEC Filing
Jun 14, 2024
04:42 PM EDT, 06/14/2024 (MT Newswires) -- Patrick O. Zalupski, 10% Owner, Director, President and CEO, on June 12, 2024, sold 20,596 shares in Dream Finders Homes ( DFH ) for $568,433. Following the Form 4 filing with the SEC, Zalupski has control over a total of 60,449,919 shares of the company, with 59,044,352 shares held directly and 1,405,567 controlled...
Lifestance Health Group Insider Sold Shares Worth $332,143, According to a Recent SEC Filing
Lifestance Health Group Insider Sold Shares Worth $332,143, According to a Recent SEC Filing
Jun 14, 2024
04:42 PM EDT, 06/14/2024 (MT Newswires) -- Ryan Pardo, Chief Legal Officer and Secretary, on June 12, 2024, sold 61,508 shares in Lifestance Health Group ( LFST ) for $332,143. Following the Form 4 filing with the SEC, Pardo has control over a total of 3,297,959 shares of the company, with 746,439 shares held directly and 2,551,520 controlled indirectly. SEC...
--Claros Mortgage Trust Keeps Quarterly Dividend at $0.25 Per Share; Payable July 15 to Shareholders of Record June 28
--Claros Mortgage Trust Keeps Quarterly Dividend at $0.25 Per Share; Payable July 15 to Shareholders of Record June 28
Jun 14, 2024
04:43 PM EDT, 06/14/2024 (MT Newswires) -- Price: 8.09, Change: +0.01, Percent Change: +0.12 ...
Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer
Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer
Jun 14, 2024
04:43 PM EDT, 06/14/2024 (MT Newswires) -- Amgen ( AMGN ) said late Friday the US Food and Drug Administration has cleared Blincyto to treat adults and children one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia, an aggressive type of blood cancer. The FDA approval, which is the third indication for Blincyto, covers people with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved